SAN FRANCISCO — Use of PET imaging to monitor treatment — and switch from ineffective therapy — led to more than a fourfold improvement in pathologic complete response (pCR) for patients with esophageal cancer, a randomized trial showed.
http://www.medpagetoday.com/meetingcoverage/mgics/62623
PET-Guided Therapy Switch for Esophageal Cancer